News and Updates

SMaRT-IO: Invitation to Participate in a National Multi-Centre Service Evaluatio

Posted: 04.11.26 by .

SMaRT-IO: Invitation to Participate in a National Multi-Centre Service Evaluation

Immunobuddies Live ESMO 2026 - Live & In Person

Posted: 15.10.26 by .

Immunobuddies Live ESMO 2026 - Live & In Person

Join the IOCN at ESMO Congress 2026

Posted: 15.10.26 by .

Join the IOCN at ESMO Congress 2026 - Cutaneous Squamous Cell Carcinoma: An Illustrative Case for Immune Checkpoint Inhibitors

Advance the Management of Immunotherapy Toxicities Through Case Conundrums

Posted: 05.06.26 by .

Advance the Management of Immunotherapy Toxicities Through Case Conundrums

World Cancer Day 2026

Posted: 04.02.26 by .

world cancer day 2026 IOCN thank you to members

Immunosuppressant access for the treatment of ICI adverse events

Posted: 31.10.25 by .

Immunosuppressant access for the treatment of ICI adverse events - a IOCN UK-wid

Service Showcase Webinar Launch - Thursday 23rd October

Posted: 21.10.25 by .

Service Showcase Webinar Launch 23/10/2025

Advance the management of immunotherapy toxicities through case conundrums

Posted: 03.10.25 by Alexandra Johnson.

IOCN Event - Advance the management of immunotherapy toxicities through case conundrums

Launching The IOCN Service Showcase Webinar Series!

Posted: 16.09.25 by .

IOCN Service Showcase Webinar Series to showcase nationwide IO Services

Survey: Fertility and the Use of Immune Checkpoint Inhibitor Therapy

Posted: 12.09.25 by .

The purpose of this questionnaire is to detect variation and consistency across UK oncology practice in regards to managing patients of childbearing age who are planned for, or have previously received immune checkpoint inhibitor (ICI) therapy